Molecular mechanisms and pathophysiology of meibomian gland dysfunction
Experimental Eye Research · 2026-06 · 267 · 110970
DOI: 10.1016/j.exer.2026.110970 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Experimental Eye Research, 2026-06. Verfasst von Liu Yang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Henan Key Laboratory of Ophthalmology and Visual Science, Henan Eye Hospital, Henan Provincial People's Hospital, People's Hospital of Zhengzhou Univ…. Hauptthemen laut MEDLINE: Meibomian Gland Dysfunction, Meibomian Glands, Tears. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 145 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Meibomian gland dysfunction (MGD) is the leading cause of evaporative dry eye disease and arises from failure of a coordinated molecular network that normally maintains meibomian gland homeostasis. In health, endocrine-lipidogenic signaling via peroxisome proliferator-activated receptor-γ (PPARγ) and androgen receptor (AR), trophic pathways such as epidermal growth factor and Hedgehog, a circadian-metabolic axis coupling nicotinamide adenine dinucleotide (NAD+)-dependent steroidogenesis to lipid output, and neuroimmune circuits involving Toll-like receptors and nuclear factor-κB (NF-κB) act together to regulate stem/progenitor maintenance, meibocyte differentiation and lipid secretion. In MGD these axes become progressively uncoupled: hormonal and metabolic stress reduce NAD+ and intracrine androgen production, dampening AR-PPARγ activity; loss of trophic support exhausts basal progenitor pools; and chronic NF-κB-driven inflammation with Th17 and interleukin-33 (IL-33) signaling promotes ductal hyperkeratinization, acinar loss and fibrosis. Lipidomic studies show a shift from cholesteryl esters (CEs) toward free fatty acids, along with remodeling of O-acyl-ω-hydroxy fatty acid (OAHFA) profiles, oxidized lipids and eicosanoids, which stiffen meibum, destabilize the tear film lipid layer and fuel inflammation. Recent single-cell and organoid studies further map cellular heterogeneity and disease-linked lineage changes. Biomarkers such as cholesteryl ester/wax ester ratios, OAHFA profiles, eicosanoids, cytokines and imaging metrics offer read-outs of axis-specific dysfunction. Therapeutically, emerging strategies seek to correct these defects by enhancing AR-PPARγ signaling and NAD+-dependent steroidogenesis, re-engaging trophic pathways, normalizing ductal keratinization with "soft" keratolytics and inhibiting inflammatory circuits. This review integrates these mechanisms, disease networks, biomarker signatures and interventions into a unified model to support mechanism-based, biomarker guided precision care in MGD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Henan Key Laboratory of Ophthalmology and Visual Science, Henan Eye Hospital, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, People's Hospital of Henan University, Zhengzhou, Henan, 45000…
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Yang, L., & Li, Z. (2026). Molecular mechanisms and pathophysiology of meibomian gland dysfunction. Experimental Eye Research, 267, 110970. https://doi.org/10.1016/j.exer.2026.110970
Vancouver
Yang L, Li Z. Molecular mechanisms and pathophysiology of meibomian gland dysfunction. Experimental Eye Research. 2026;267:110970. doi:10.1016/j.exer.2026.110970
BibTeX
@article{Yang2026,
author = {Yang, Liu and Li, Zhijie},
title = {Molecular mechanisms and pathophysiology of meibomian gland dysfunction},
journal = {Experimental Eye Research},
year = {2026},
volume = {267},
pages = {110970},
doi = {10.1016/j.exer.2026.110970}
}
EUVIMED